COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Financial calendar 2018
13/12/2017
Announcement no. 87/2017 Financial calendar 13 December 2017 Financial calendar 2018 Össur's financial calendar for 2018 Interim Report Q1 2018 25 April 2018 Interim Report Q2 2018 25 July 2018 Interim Report Q3 2018 24 [...]
Allakos Secures $100 Million In Series B Financing
13/12/2017
Proceeds will support advancement of AK002 in five disease areas Lead clinical program evaluating AK002 in eosinophilic gastroenteritis, an inflammatory gastrointestinal disease SAN CARLOS, Calif., Dec. 13, 2017 (GLOBE [...]
NSS Labs Announces Industry’s First Breach Prevention System Group Test Results
13/12/2017
AUSTIN, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent fact-based cybersecurity guidance, today announced the results of its Breach Prevention Systems (BPS) [...]
Stemline Therapeutics Presents Detailed SL-401 Pivotal Data in BPDCN at ASH and Kicks Off its BPDCN Awareness Campaign; Updated Results From Ongoing Trials in Additional Malignancies Also Presented
13/12/2017
NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, presented detailed data [...]
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
13/12/2017
SEATTLE, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (Nasdaq: CASC ), a clinical-stage biopharmaceutical company, today announced that it has been selected for addition to the Nasdaq Biotechnology [...]
Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.
13/12/2017
PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that the company’s Algovita ® Spinal Cord Stimulation (SCS) system has now [...]
Amalgam Rx Partners with UCB on BEYOND™, a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis
13/12/2017
WILMINGTON, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allay Rx, a subsidiary of Amalgam Rx, Inc. , a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral and patient support [...]
Women In Bio Holds First Annual Boardroom Ready Reception & Retreat for 2016/2017 Alumni in New York
13/12/2017
Application Process for the 2018 Boardroom Ready Program begins late December BOSTON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Women In Bio (WIB) an organization of professionals committed to promoting careers, leadership, and [...]
eTrueNorth Expands its eLabNetwork™ Platform Internationally
13/12/2017
DALLAS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based healthcare technology solution provider for CLIA-waived laboratories, announced today that it has grown its business internationally with a new [...]
Xbrane Biopharma informs about changes in management team
13/12/2017
Pressrelease 2017-12-13 Xbrane Biopharma AB ("Xbrane" or "the Company") announces that Carlo Colombo, Head of Production within Xbranes long acting injectable business, who forms a part of Xbranes management team, has [...]
Nephros Receives $1.8 Million in Cash from Sale of Tax Credits
13/12/2017
SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]
Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index
13/12/2017
RADNOR, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index
13/12/2017
DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates and Highlights Pipeline Expansion at Analyst Day 2017
13/12/2017
- Generation 2 Manufacturing Process Selected for All Ongoing and Future TIL Clinical Development - - Company Reports Updated Results for Cohort 2 in Melanoma Study - - Two New Studies in NSCLC Patients in Collaboration [...]
Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer
13/12/2017
Moffitt Cancer Center Phase 1 Study Combining TIL and Nivolumab Initiated in NSCLC Patients Iovance/MedImmune Clinical Collaboration to Initiate with Start of Phase 2 Study in PD-1/PDL-1 Naïve NSCLC Patients 1H 2018 SAN [...]
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.
13/12/2017
LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
National Research Corporation Announces Revised Class B Common Stock Recapitalization Plan
13/12/2017
All class B shares to be exchanged for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share Class A common stock to be sole outstanding security of the Company Previously [...]
Q Therapeutics Announces Research Collaboration With REPROCELL
13/12/2017
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative [...]
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference
13/12/2017
PLEASANTON, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice [...]

Pages